Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Improved QC of radiopharmaceutcials with a dual-mode instrument for combined r-HPLC and r-TLC analysis

Tom Deakin, Elvir Zahirovic, Jonathan Lowe, Richard Brown and John Clapham
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 332;
Tom Deakin
1Physics and Astronomy, The University of Sheffield, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elvir Zahirovic
2LabLogic Systems Limited, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Lowe
3Wolfson Molecular Imaging Centre, Manchester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Brown
2LabLogic Systems Limited, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Clapham
2LabLogic Systems Limited, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

332

Objectives Radiochromatography data form a key part of the QC that is undertaken on radiopharmaceuticals before release. In Europe, there is a demand for using both r-HPLC and r-TLC in order to quantify the radiochemical purity of the sample, which requires a substantial outlay in terms of both equipment cost and the amount of laboratory space. Here, we describe the development and testing of a dual-mode radiochromatography instrument that is capable of performing r-HPLC and r-TLC analyses simultaneously and independently and offers a very small footprint (<0.25 m2) when compared to the use of two separate instruments

Methods In developing the system, particular attention has been paid to detector optimisation for both chromatographic techniques in order to offer flexibility of use with PMT and PiN-diode based detectors. These have been coupled to a range of scintillators to enable complete characterisation for a wide range of gamma energies, whilst maintaining linearity. In addition, methods to optimise the collimation geometry in order to provide the best peak resolution for r-TLC are described (Fig 1). A bespoke control and DAQ package has been developed in parallel to the instrument to link chromatographic and spectral data for PET QC applications and provide compatibility with a PET LIMS.

Results Tests of the system with samples of 18F-FDG and 137Cs calibration standards (662 keV gammas) have confirmed the suitability of the system to perform routine r-HPLC and r-TLC measurements for radiochemical purity purposes, giving good primary peak resolution for sampling times between 200 and 1000 ms and low backgrounds to illuminate the presence of <1% impurity peaks.

Conclusions The development and testing has proven suitability for operation in the PET-QC environment. Current work is focusing on the integration of a compact digital pulse processor (DPP) to provide real-time spectrometric information and hence add an additional operational mode to the system.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improved QC of radiopharmaceutcials with a dual-mode instrument for combined r-HPLC and r-TLC analysis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Improved QC of radiopharmaceutcials with a dual-mode instrument for combined r-HPLC and r-TLC analysis
Tom Deakin, Elvir Zahirovic, Jonathan Lowe, Richard Brown, John Clapham
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 332;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Improved QC of radiopharmaceutcials with a dual-mode instrument for combined r-HPLC and r-TLC analysis
Tom Deakin, Elvir Zahirovic, Jonathan Lowe, Richard Brown, John Clapham
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 332;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
  • Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Current Topics in PET Drug Quality Assurance

  • A review of the implementation of a Media fill simulation program that complies with FDA regulation
  • “Dekavil” cytokine fusion protein automated iodine-124 radiolabelling for PET imaging: production, QC & biodistribution studies in mice
  • A comparative study of Endosafe® PTS system and standard assay methods for Endotoxin Test of [18F]FDG, [11C]PiB and [13N]NH
Show more Current Topics in PET Drug Quality Assurance

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire